Drug and Medication Analysis & Statistics in France, April 2014 (p2)

31-60 of 71 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Italy, France, Germany, Spain, United Kingdom
Pharmaceuticals in France, MarketLine

Pharmaceuticals in France, MarketLine

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology
  • Countries : France
French Hospital Microbiology Testing Market 2014

French Hospital Microbiology Testing Market 2014

  • $ 2 900
  • Industry report
  • January 2014
  • by Venture Planning Group

This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital microbiology testing market, including: - Major issues pertaining ...

  • Industries : Drug and Medication
  • Countries : France
World Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

World Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 21 800
  • Industry report
  • January 2014
  • by Venture Planning Group

"World Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies" is a new seven-country strategic analysis ...

  • Industries : Drug and Medication
  • Countries : Germany, France
French Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies

French Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • January 2014
  • by Venture Planning Group

"French Clinical Chemistry and Immunodiagnostic Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies" is a new strategic analysis of major business opportunities emerging in the French ...

  • Industries : Drug and Medication
  • Countries : France
European Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

European Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 12 800
  • Industry report
  • January 2014
  • by Venture Planning Group

"European Clinical Chemistry and Immunodiagnostic Market 2014: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies" is a new five-country strategic analysis of majo ...

  • Industries : Drug and Medication
  • Countries : Germany, France
PharmaPoint: Microvascular Complications of Diabetes - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • December 2013
  • by Global Data

PharmaPoint: Microvascular Complications of Diabetes - France Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, ...

  • Industries : Drug and Medication
  • Countries : France
2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Market

2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Market

  • $ 12 800
  • Industry report
  • December 2013
  • by Venture Planning Group

"2014 Opportunities in the European Clinical Chemistry and Immunodiagnostic Market” is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Drug and Medication
  • Countries : Germany, France, Spain, Italy
2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Market

2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Market

  • $ 3 950
  • Industry report
  • December 2013
  • by Venture Planning Group

“2014 Opportunities in the French Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the French clinical chemistry and immunodiagnostic ...

  • Industries : Drug and Medication
  • Countries : France
2014 Opportunities in the French Therapeutic Drug Monitoring (TDM) Market

2014 Opportunities in the French Therapeutic Drug Monitoring (TDM) Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 247-page report from Venture Planning Group provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Drug and Medication
  • Countries : France
2014 Opportunities in the French Endocrine Function Testing Market

2014 Opportunities in the French Endocrine Function Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Drug and Medication
  • Countries : France
2014 Opportunities in the French Drugs of Abuse Testing Market

2014 Opportunities in the French Drugs of Abuse Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Obesity - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Obesity - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • October 2013
  • by Global Data

PharmaPoint: Obesity - France Drug Forecast and Market Analysis to 2022 Summary After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies ...

  • Industries : Pathology, Drug and Medication
  • Countries : France
2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 12 800
  • Industry report
  • October 2013
  • by Venture Planning Group

2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies is a new five-country strategic ...

  • Industries : Drug and Medication
  • Countries : Germany, France, Spain, Italy
2014 Analysis of the French Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Analysis of the French Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • October 2013
  • by Venture Planning Group

2014 Analysis of the French Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies is a new strategic analysis of major business opportunities emerging ...

  • Industries : Drug and Medication
  • Countries : France
RANBAXY - Stretched Balance Sheet, a Weak Product Pipeline, and Uncertainty around Monetizing Exclusivities

RANBAXY - Stretched Balance Sheet, a Weak Product Pipeline, and Uncertainty around Monetizing Exclusivities

  • $ 140
  • Company report
  • August 2013
  • by MP Advisors

Q2 CY-13 Result in Line: Sales grew by 8% QoQ primarily on account of higher Absorica (Isotretinoin) sales in US. US sales grew by 29% sequentially as company now has 14% share in Isotretinion (~$400m ...

  • Countries : France
Global Clinical Chemistry and Immunodiagnostic Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

Global Clinical Chemistry and Immunodiagnostic Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 21 800
  • Industry report
  • August 2013
  • by Venture Planning Group

This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; ...

  • Industries : Drug and Medication
  • Countries : Germany, Japan, Italy, France
France Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

France Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • August 2013
  • by Venture Planning Group

This comprehensive report contains 542 pages and 104 tables. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - France Drug Forecast and Market ...

  • Industries : Drug and Medication, Pathology
  • Countries : France
PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Chronic Heart Failure - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - France Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - France Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in ...

  • Industries : Drug and Medication
  • Countries : France
Laboratoires McNeil in Consumer Health (France)

Laboratoires McNeil in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires McNeil is a Johnson & Johnson Inc company. This manufacturer is present in several categories, such as digestive remedies, analgesics, eye care, dermatologicals and NRT smoking cessation aids. ...

  • Industries : Drug and Medication
  • Countries : France
Novartis Group France SA in Consumer Health (France)

Novartis Group France SA in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Novartis Group France is likely to pursue the vision set at group level by Novartis AG in Switzerland. With a strong focus on eye care noted at group level, it is likely that the company will attempt to ...

  • Industries : Drug and Medication, Healthcare
  • Countries : France
Cooperation Pharmaceutique Francaise SAS (Cooper) in Consumer Health (France)

Cooperation Pharmaceutique Francaise SAS (Cooper) in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Cooper’s strategy will focus on the development and promotion of strong brands in the French consumer health market. It will also continue to consolidate its well-known products, such as the Pouxit range ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia, France
Pierre Fabre SA, Laboratoires in Consumer Health (France)

Pierre Fabre SA, Laboratoires in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Pierre Fabre Group’s strategic vision is to expand further in the international arena, especially in emerging countries such as China, Brazil and Turkey. The focus is on dermo-cosmetic international ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia, France
UPSA, Laboratoires in Consumer Health (France)

UPSA, Laboratoires in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires UPSA will continue to focus on those consumer health categories in which it has a strong position. As a key part of its strategy, advertising and communication will continue to remain strong ...

  • Industries : Drug and Medication, Healthcare
  • Countries : France
Ear Care in France

Ear Care in France

  • $ 1 064
  • Industry report
  • June 2013
  • by Euromonitor International

In September 2012, Otipax, a common ear care product in France, was fully delisted from the official reimbursement list (listed at a 15% reimbursement rate until August 2012). This clearly confirms the ...

  • Industries : Healthcare
  • Countries : France
Emergency Contraception in France

Emergency Contraception in France

  • $ 1 064
  • Industry report
  • June 2013
  • by Euromonitor International

The contraceptive model in France drastically changed in recent years, with the advent of new hormonal methods of contraception, such contraceptive implants, contraceptive skin patches and vaginal rings. ...

  • Industries : Drug and Medication
  • Countries : France
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs

2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : France
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Methotrexate Markets in France

  • February 2015
    4 pages
  • Methotrexate  

  • France  

View report >

Drug Industry - Forecast

December 2014

Drug Industry In France

November 2014

Pathology Description

August 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.